Amedisys Stock Target Price and Analyst Consensus
| AMED Stock | USD 97.52 0.61 0.63% |
The current analyst and expert consensus on Amedisys is Hold with 9 hold recommendations. The current projected Amedisys target price consensus is 96.17 with 11 analyst opinions. One of the most common ways Amedisys analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Amedisys vendors, executives, and/or customers. Amedisys recommendation module provides expert sentiment on the projected Amedisys target price to derive its highest and lowest estimates based on target price standard deviation. Check out Macroaxis Advice on Amedisys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Lowest Forecast 87.51 | Highest Forecast 106.75 | Target Price 96.17 |
It's important to approach Amedisys' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Amedisys Target Price Consensus
Amedisys target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Amedisys' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 11 | Hold |
Most Amedisys analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Amedisys stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Amedisys, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAmedisys Target Price Projection
Amedisys' current and average target prices are 97.52 and 96.17, respectively. The current price of Amedisys is the price at which Amedisys is currently trading. On the other hand, Amedisys' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Amedisys Target Price
Amedisys Analyst Ratings
Amedisys' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Amedisys stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Amedisys' financials, market performance, and future outlook by experienced professionals. Amedisys' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Amedisys price targets
Amedisys' stock target price is an estimate of its future price, usually made by analysts. Using Amedisys' target price to determine if it is a suitable investment can be done through the following steps:- Look at Amedisys' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Amedisys' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Amedisys Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amedisys is a key component of Amedisys valuation and have some predictive power on the future returns of a Amedisys.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amedisys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Target Risk ETFs Invested over 200 shares | |
| Broad Equity ETFs Invested over 100 shares | |
| Strategy ETFs Invested over 100 shares | |
 | Macroaxis Index Invested over 500 shares | |
| Single Stock ETFs Invested over 100 shares | |
 | Real Estate Invested over 100 shares | |
Check out Macroaxis Advice on Amedisys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Please note, the presentation of Amedisys' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amedisys' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Amedisys' management manipulating its earnings.